RJ van de Griend

Killing of human leukaemia/lymphoma B cells by activated cytotoxic T lymphocytes in the presence of a bispecific monoclonal antibody (αCD3/αCD19)

Inez-Anne Haagen, RJ van de Griend, Mike Clark et al. · Clinical & Experimental Immunology · 1992 · 31 citations · Full text

Killing of autologous B-lineage malignancy using CD3 x CD19 bispecific monoclonal antibody in end stage leukemia and lymphoma

IA Haagen, AJ Geerars, WB de Lau et al. · Blood · 1994 · 27 citations · Full text

In vitro expansion and analysis of cloned cytotoxic T cells derived from patients with chronic T gamma lymphoproliferative disorders

RJ van de Griend, RL Bolhuis · Blood · 1985 · 24 citations · Full text

Enzyme analysis of lymphoproliferative diseases: a useful addition to cell surface phenotyping

RJ van de Griend, HJ van der Reijden, RL Bolhuis et al. · Blood · 1983 · 21 citations · Full text